Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Arcus Biosciences stock have an average target of 29.5, with a low estimate of 17 and a high estimate of 44. The average target predicts an increase of 259.76% from the current stock price of 8.20.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$29.5	$29	$44
Change	+107.32%	+259.76%	+253.66%	+436.59%

* Price targets were last updated on Feb 26, 2025.

Analyst Ratings

The average analyst rating for Arcus Biosciences stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	4	3
Buy	6	6	6	6	6	6
Hold	2	2	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	11	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $24	Hold → Strong Buy	Upgrades	$24	+192.68%	Feb 26, 2025
Jason Zemansky B of A Securities	B of A Securities	Hold Maintains $22 → $17	Hold	Maintains	$22 → $17	+107.32%	Feb 19, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $20 → $18	Hold	Maintains	$20 → $18	+119.51%	Feb 18, 2025
Terence Flynn Morgan Stanley	Morgan Stanley	Buy Maintains $36 → $25	Buy	Maintains	$36 → $25	+204.88%	Feb 18, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $20	Hold	Reiterates	$20	+143.90%	Nov 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

163.82M

Decreased by -36.50%

from 258.00M

Revenue Next Year

209.81M

Increased by 28.07%

from 163.82M

EPS This Year

-4.70

from -3.14

EPS Next Year

-4.42

from -4.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	78.00M	383.00M	112.00M	117.00M	258.00M	163.82M	209.81M	257.96M
Revenue Growth	420.00%	391.03%	-70.76%	4.46%	120.51%	-36.50%	28.07%	22.95%
EPS	-2.24	0.71	-3.71	-4.15	-3.14	-4.70	-4.42	-4.71
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	12	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	326.6M	421.3M	390.3M
Avg	163.8M	209.8M	258.0M
Low	78.4M	88.2M	56.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	26.6%	157.2%	86.0%
Avg	-36.5%	28.1%	22.9%
Low	-69.6%	-46.2%	-73.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-3.56	-1.93	-2.35
Avg	-4.70	-4.42	-4.71
Low	-6.60	-6.08	-6.05

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.